References

2. Wold, W. S., Hermiston, T. W., and Tollefson, A. E. (1994). Trends Microbiol. 2, 437-443.

3. Sparer, T. E., Tripp, R. A., Dillehay, D. L., Hermiston, T. W., Wold, W. S., and Gooding, L. R. (1996)./. Virol. 70, 2431-2439.

4. Rodriguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., and Henderson, D. R. (1997). Cancer Res. 57, 2559-2563.

5. Heise, C., Williams, A., Xue, S., Propst, M., and Kirn, D. (1999b). Cancer Res. 59,2623-2628.

6. Heise, C., Williams, A., Olesch, J., and Kirn, D. (1999a). Cancer Gene Tber. 6.

7. Wickham, T. J., Segal, D. M., Roelvink, P. W., Carrion, M. E., Lizonova, A., Lee, G. M., and Kovesdi, I. (1996)./. Virol. 70, 6831-6838.

8. Heise, C., and Kirn, D. (2000). /. Clin. Invest. 105, 847-851.

9. Shenk, T. (1996). In "Fields Virology" (K. Howley, Ed.), pp. 2135-2137. Lippincott-Raven: Philadelphia.

10. Wold, W. S., Tollefson, A. E., and Hermiston, T. W. (1995). Curr. Top. Microbiol. Immunol. 199, 237-274.

11. Dimitrov, T., Krajcsi, P., Hermiston, T. W., Tollefson, A. E., Hannink, M., and Wold, W. S. (1997)./. Virol. 71,2830-2837.

12. Hermiston, T. W., Tripp, R. A., Sparer, T., Gooding, I.. R., and Wold, W. S. (1993). /. Virol. 67, 5289-5298.

13. Shisler, J., Duerksen, H. P., Hermiston, T. M., Wold, W. S., and Gooding, L. R. (1996). /. Virol. 70, 68-77.

14. Tollefson, A. E., Ryerse, J. S., Scaria, A., Hermiston, T. W., and Wold, W. S. (1996). Virology 220, 152-62.

15. Gooding, L. R. (1994). Infect. Agents Dis. 3, 106-115.

16. Toda, M., Rabkin, S., Kojima, H., and Martuza, R. (1999). Hum. Gene Ther. 10, 385-393.

17. Martuza, R. (2000)./. Clin. Invest. 105, 841-846.

18. Whyte, P., Ruley, H., and Harlow, E. (1988). /. Virol. 62, 257-265.

19. Yu, D., Sakamoto, G., and Henderson, D. R. (1999). Cancer Res. 59, 1498-1504.

20. Hallenbeck, P. Chang, Y., Hay, C., Phipps, S., and Chiang, Y. (1999). Hum. Gene Ther. 10(10), 1721-1733.

21. Kurihara, T., Brough, D. E., Kovesdi, 1., and Kufe, D. W. (2000). /. Clin. Invest. 106, 763-771.

22. Barker, D. D., and Berk, A. J. (1987). Virology 156, 107-121.

23. Nielsch, U., Fognani, C., and Babiss, L. E. (1991). Oncogene 6, 1031-1036.

25. Olson, D. C., and Levine, A. J. (1994). Cell Growth Differ, 5, 61-71.

26. Kirn, D., Heise, C., Williams, M., Propst, M., and Hermiston, T. (1998a). "Cancer Gene Therapy" Sobol (Ed.). San Diego.

27. Martuza, R. L., Malick, A., Markert, J. M., Ruffner, K. L., and Coen, D. M. (1991). Science 252, 854-856.

28. Mineta, T., Rabkin, S. D., Yazaki, T., Hunter, W. D., and Martuza, R. L. (1995). Nat. Med. 1, 938-943.

29. Whyte, P., Williamson, N., and Harlow, E. (1989). Cell 56, 67-75.

30. Hu, Q. J., Dyson, N. and Harlow, E. (1990). EMBO ]. 9, 1147-1155.

31. Heise, C., Hermiston, T., Johnson, L., Brooks, G., Sampson-Johannes, A., Williams, A., Hawkins, L., and Kirn, D. (2000a). Nat. Med. 6, 1134-1139.

32. Fueyo, J., Gomez-Manzano, C., Alemany, R., Lee, P., McDonnell, T., Mitlianga, P., Shi, Y., Levin, v., Yung, W., and Kyritsis, A. (2000). Oncogene 19, 2-12.

33. Scheffner, M., Munger, K., Byrne, J. C., and Howley, P. M. (1991). Proc. Natl. Acad. Sei. USA 88, 5523-5527.

34. Zhang, Y., Xiong, Y., and Yarbrough, W. G. (1998). Cell 92, 725-734.

35. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991). Science 253, 49-53.

36. Dobner, T., Horikoshi, N., Rubenwolf, S., and Shenk, T. (1996). Science 272, 1470-1473.

37. Yew, P. R., Liu, X., and Berk, A. J. (1994). Genes Dev., 8, 190-202.

38. Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., and McCormick, F. (1996). Science 274, 373-376.

39. Rogulski, K., Freytag, S., Zhang, K., Gilbert, J., Paielli, D., Kim, J., Heise, C., and Kirn, D. H. (2000). Cancer Res. 60, 1193-1196.

40. Rothmann, T., Hengstermann, A., Whitaker, N. J., Scheffner, M., and zur Hausen, H. (1998). /. Virol. 72, 9470-9478.

41. Ries, S.J., Brandts, C. H., Chung, A. S., Biederer, C. H., Hann, B.C., Lipner, E. M., McCormick, F., and Michael Korn, W. (2000). Nat. Med. 6, 1128-1133.

42. Heise, C., Sampson, J. A., Williams, A., McCormick, F., Von, H. D., and Kirn, D. H. (1997a). Nat. Med. 3, 639-645.

43. Goodrum, F. D., and Ornelles, D. A. (1997)./. Virol. 71, 548-561.

44. Goodrum, F. D., and Ornelles, D. A. (1998)./. Virol. 72, 9479-9490.

45. Southam, C. M., and Moore, A. E. (1952). Cancer 5, 1025-1034.

47. Smith, R., Huebner, R. J., Rowe, W. P., Schatten, W. E., and Thomas, L. B. (1956). Cancer 9, 1211-1218.

48. Ganly, I., Kirn, D., Eckhardt, S., Rodriguez, G., Souter, D., Von Hoff, D., and Kaye, S. (2000). Clin. Cancer Res. 6, 798-806.

49. Nemunaitis, J., Ganly, I., Khuri, F., Arsenau, J., Kuhn, J., McCarty, T., Landers, S., Maples, P., Romel, L., Randlev, B., Reid, T., Kaye, S., and Kirn, D. (2000b). Cancer Res. 60, 6359-6366.

50. Vasey, P., Shulman, L., Gore, M., Kirn, D., and Kaye, S. (2000). Proc. Am. Soc. Clin. Oncol.

51. Reid, A., Galanis, E., Abbruzzese, J., Romel, L., Rubin, J., and Kirn, D. (1999). "EORTC-NCI-AACR Meeting on Molecular Therapeutics of Cancer."

52. Nemunaitis, J., Cunningham, C., Randlev, B., and Kirn, D. (2000a). Proc. Am. Soc. Clin. Oncol. 19, 724 (abstract).

53. Nemunaitis, J., Khuri, F., Posner, M., Vokes, E., Romel, L., and Kirn, D. (2000c). Cancer Res. 60, (22), 6359-6366.

54. Reid, T., Galanis, E., Abbruzzese, J., Randlev, B., Romel, L., Rubin, J., and Kirn, D. (2000). Proc. Am. Soc. Clin. Oncol. 19, 953 (abstract).

55. Khuri, F., Nemunaitis, J., Ganly, I., Gore, M., MacDougal, M., Tannock, I., Kaye, S., Hong, W., and Kirn, D. (2000). Nat. Med.

56. Hecht, R., Abbruzzese, J., Bedford, R., Randlev, B., Romel, L., Lahodi, S. and Kirn, D. (2000). Proc. Am. Soc. Clin. Oncol. 19, 1039 (abstract).

57. Kirn, D., Hermiston, T., and McCormick, F. (1998b). Nat Med. 4, 1341-1342.

58. Roelvink, P., Mi, G., Einfeld, D., Kovesdi, I., and Wickham, T. (1999). Science 286, 1568-1571.

59. Douglas, J. T., Rogers, B. E., Rosenfeld, M. E., Michael, S. I., Feng, M., and Curiel, D. T. (1996). Nat. Biotechnol. 14, 1574-1578.

61. Sauthoff, H., Heitner, S., Rom, W., and Hay, J. (2000). Hum. Gene Ther. 11, 379-388.

62. Medina, D. J., Sheay, W., Goodell, L., Kidd, P., White, E., Rabson, A. B., and Strair, R. K. (1999). Blood 94, 3499-3508.

63. Doronin, K., Toth, K., Kuppuswamy, M., Ward, P., Tollefson, A., and Wold, W. (2000). /. Virol. 74, 6147-6155.

64. Hermiston, T. (2000)./. Clin. Invest. 105, 1169-1172.

65. Hawkins, L., Nye, J., Castro, D., Johnson, L., Kirn, D., and Hermiston, T. (1999). Proc. Am. Assoc. Cancer Res. 40, 476.

66. Freytag, S. O., Rogulski, K. R., Paielli, D. L., Gilbert, J. D., and Kim, J. H. (1998). Hum. Gene Tber. 9, 1323-1333.

67. Wildner, O., Blaese, R. M., and Morris, J. M. (1999). Cancer Res. 59, 410-413.

68. Heise, C., Lemmon, M., and Kirn, D. (2000b). Clin. Cancer Res.

69. Nemunaitis, J., Cunningham, C., Buchaman, A., Randler, B., Olson, S., and Kirn, D. (2001). Gene Ther. 8 (10), 746-759.

70. Agha-Mohammadi, S., and Lotze, M. (2000)./. Clin. Invest. 105, 1173-1176.

71. Norman, K., and Lee, P. (2000)./. Clin. Invest. 105, 1035-1038.

72. Mastrangelo, M., Eisenlohr, L., Gomella, L., and Lattime, E. (2000). J. Clin. Invest. 105, 1031-1034.

73. Coffey, M., Strong, J., Forsyth, P., and Lee, P. (1998). Science 282, 1332-1334.

75. Lattime, E. C., Lee, S. S., Eisenlohr, L. C., and Mastrangelo, M. J. (1996). Semin. Oncol. 23, 88-100.

76. Low, K., Ittensohn, M., Le, T., Piatt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., Lin, S., Luo, X., Miller, S., Zheng, L., King, I., Pawelek, J., and Bermudes, D. (1999). Nat. Biotechnol. 17, 37-41.

77. Sznol, M., Lin, S., Bermudes, D., Zheng, L., and King, I. (2000). /. Clin. Invest. 105, 1027-1030.

78. Heise, C., Sampson-Johannes, A., Williams, A., McCormick, F., Von Hoff, D. D. and Kirn, D. H. (1997b). Nat. Med. 3, 639-645.

Was this article helpful?

0 0

Post a comment